T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Completed · Phase 2

Conditions studied: HIV Infections

In brief

This study will evaluate T-20 in children.

Key facts

Study ID

NCT00022763

Run by

Hoffmann-La Roche

People needed

52

Starts

2001-08-01

Last updated by the study team

2016-02-15

Who can join

Age: 3 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are 3 through 16 years of age and have the consent of parent or guardian.
• Have a viral load of at least 5000 copies/ml.
• Have taken at least 2 of the 3 licensed anti-HIV drug classes for at least 3 months.
• Have been on stable therapy for at least 4 weeks.

Where it is running

• Children's Hosp Los Angeles — Los Angeles, California, United States
• Univ of Florida Gainesville — Gainesville, Florida, United States
• New York Hosp - Cornell / Program for Children with AIDS — New York, New York, United States
• Mount Sinai Hosp — New York, New York, United States
• Bronx Lebanon Hosp Ctr — The Bronx, New York, United States
• Bronx Municipal Hosp Ctr/Jacobi Med Ctr — The Bronx, New York, United States
• Children's Hosp of the King's Daughters — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.